Latest Posts:
  • The UK-Switzerland FTA and the Internationalisation of Pharmaceutical Exclusivity
  • Impact of MFN Pricing on Transactions
  • United States: HHS-OIG Issues Unfavorable Advisory Opinion on Physician Royalty Arrangements with Device Company
  • United States: President Trump Tariffs on Patented Pharmaceuticals Under Section 232
  • The US BIOSECURE Act Becomes Law: Implications for Collaborations with “Biotechnology Companies of Concern”
  • Manufacturing Site Divestitures: Best Practices for Successful Execution
  • Medical Device AI in Limbo: EU’s Digital Overhaul or Digital Headache for Pharma and Medtech?
  • EU Biotech Act Unveiled: Commission’s Proposal to Turn Europe into a Biotech Powerhouse
Search for:
Healthcare & Life Sciences Blog
  • Focus Areas
    • Digital Health
    • EU Pharmaceutical Package
    • Health Data Privacy & Security
    • Healthcare Services
    • Medical Devices
    • Pharmaceuticals & Biotech
  • Search for:
Author

Roberto Cursano

Browsing
  • Subscribe for Regular Alerts
  • Related Websites
    HLS HUB
  • Archives

© Copyright 2026 – Healthcare & Life Sciences Blog

  • Disclaimers
  • Privacy Statement
  • Attorney Advertising

{copy} {year} ThemeSphere. Designed by ThemeSphere.

Top
  • Focus Areas
    • Digital Health
    • EU Pharmaceutical Package
    • Health Data Privacy & Security
    • Healthcare Services
    • Medical Devices
    • Pharmaceuticals & Biotech